Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?

One company is growing a commercial drug business with limited margin for error on the path to profitability. The other has a platform that proved itself at global scale and keeps finding new diseases…

  • Axsome Therapeutics focuses on CNS conditions with AUVELITY, SUNOSI, and SYMBRAVO
  • Moderna leverages mRNA technology for broad therapeutic applications beyond COVID-19
  • Both companies operate in high-risk, high-reward biopharmaceutical environment

More from Friday 18 September →